Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 11, 2016 11:12 PM ET

Life Sciences Tools and Services

Company Overview of Ngen, Inc.

Company Overview

Ngen, Inc., a diagnostics company, develops, manufactures, and sells diagnostic products for use in the in vitro diagnostic market in the United States, Canada, and Europe. It offers diagnostic test kits and reagents based on polymerase chain reaction (PCR) technology in the molecular diagnostic market. The company’s PCR molecular product lines comprise Q-PCR Alert products for in-vitro diagnostic use, and are sold in Italy via a contract sales force and in other European countries through a network of distributors; and MGB Alert products. It also offers point-of-care products, which include qualitative cardiac test products that are rapid test assays used in emergency care settings for the ...

10398 Pacific Center Court

San Diego, CA 92121

United States

Founded in 1993





Key Executives for Ngen, Inc.

Ngen, Inc. does not have any Key Executives recorded.

Ngen, Inc. Key Developments

SEC Revokes Registration Of Registered Securities Of Nanogen

An Administrative Law Judge has issued an Initial Decision of Default as to Nanogen, Inc.. The Initial Decision found that the company was issuer of securities registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (Exchange Act), and the company failed to comply with Section 13(a) of the Exchange Act and Exchange Act Rules 13a-1 and/or 13a-13 by not filing required periodic reports with the Securities and Exchange Commission (SEC). The Initial Decision finds these allegations to be true and revokes the registration of each class of the company’s registered securities, pursuant to Section 12(j) of the Securities Exchange Act of 1934.

Similar Private Companies By Industry

Company Name Region
Chemica Technologies, Inc. United States
Formatech, Inc. United States
Acoustic Cytometry Systems, Inc. United States
Clinical Trials Services, Inc. United States
Pharmaceutical Resource Associates Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ngen, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at